These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

756 related items for PubMed ID: 16824659

  • 1. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes.
    Odagaki Y, Toyoshima R.
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1304-12. PubMed ID: 16824659
    [Abstract] [Full Text] [Related]

  • 2. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
    Newman-Tancredi A, Audinot V, Chaput C, Verrièle L, Millan MJ.
    J Pharmacol Exp Ther; 1997 Jul 30; 282(1):181-91. PubMed ID: 9223553
    [Abstract] [Full Text] [Related]

  • 3. Dopamine D2 receptor partial agonists display differential or contrasting characteristics in membrane and cell-based assays of dopamine D2 receptor signaling.
    Jordan S, Johnson JL, Regardie K, Chen R, Koprivica V, Tadori Y, Kambayashi J, Kitagawa H, Kikuchi T.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar 30; 31(2):348-56. PubMed ID: 17070976
    [Abstract] [Full Text] [Related]

  • 4. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J, Makkai B, Gulyás B, Hall H.
    Eur J Neurosci; 2005 Jul 30; 22(1):65-71. PubMed ID: 16029196
    [Abstract] [Full Text] [Related]

  • 5. Action of novel antipsychotics at human dopamine D3 receptors coupled to G protein and ERK1/2 activation.
    Bruins Slot LA, Palmier C, Tardif S, Cussac D.
    Neuropharmacology; 2007 Aug 30; 53(2):232-41. PubMed ID: 17588617
    [Abstract] [Full Text] [Related]

  • 6. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
    Odagaki Y, Toyoshima R.
    Eur J Pharmacol; 2005 Oct 03; 521(1-3):49-58. PubMed ID: 16182280
    [Abstract] [Full Text] [Related]

  • 7. G protein activation by human dopamine D3 receptors in high-expressing Chinese hamster ovary cells: A guanosine-5'-O-(3-[35S]thio)- triphosphate binding and antibody study.
    Newman-Tancredi A, Cussac D, Audinot V, Pasteau V, Gavaudan S, Millan MJ.
    Mol Pharmacol; 1999 Mar 03; 55(3):564-74. PubMed ID: 10051542
    [Abstract] [Full Text] [Related]

  • 8. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC, Maullu C, Onali P.
    Br J Pharmacol; 1997 Oct 03; 122(3):401-8. PubMed ID: 9351494
    [Abstract] [Full Text] [Related]

  • 9. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation.
    Wang HY, Undie AS, Friedman E.
    Mol Pharmacol; 1995 Dec 03; 48(6):988-94. PubMed ID: 8848015
    [Abstract] [Full Text] [Related]

  • 10. In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK-801) are inactive at cloned human and rat dopamine D2 receptors.
    Jordan S, Chen R, Fernalld R, Johnson J, Regardie K, Kambayashi J, Tadori Y, Kitagawa H, Kikuchi T.
    Eur J Pharmacol; 2006 Jul 01; 540(1-3):53-6. PubMed ID: 16730695
    [Abstract] [Full Text] [Related]

  • 11. Aplindore (DAB-452), a high affinity selective dopamine D2 receptor partial agonist.
    Heinrich JN, Brennan J, Lai MH, Sullivan K, Hornby G, Popiolek M, Jiang LX, Pausch MH, Stack G, Marquis KL, Andree TH.
    Eur J Pharmacol; 2006 Dec 15; 552(1-3):36-45. PubMed ID: 17056032
    [Abstract] [Full Text] [Related]

  • 12. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC, Van Scharrenburg G, Ronken E, Hesselink MB, Reinders JH, Van Der Neut M, Long SK, Feenstra RW, McCreary AC.
    Synapse; 2006 Dec 15; 60(8):599-608. PubMed ID: 17001660
    [Abstract] [Full Text] [Related]

  • 13. Segment-dependent activation of muscarinic acetylcholine receptor-mediated [35S]Guanosine-5'-O-(gamma-thiotriphosphate) binding in airway tissue membranes.
    Hajek P, Ungemach FR, Abraham G.
    Pharmacology; 2009 Dec 15; 83(4):247-58. PubMed ID: 19295255
    [Abstract] [Full Text] [Related]

  • 14. Mechanisms of agonist action at D2 dopamine receptors.
    Roberts DJ, Lin H, Strange PG.
    Mol Pharmacol; 2004 Dec 15; 66(6):1573-9. PubMed ID: 15340043
    [Abstract] [Full Text] [Related]

  • 15. 5-HT-stimulated [35S]guanosine-5'-O-(3-thio)triphosphate binding as an assay for functional activation of G proteins coupled with 5-HT1B receptors in rat striatal membranes.
    Odagaki Y, Toyoshima R.
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Feb 15; 372(5):335-45. PubMed ID: 16491386
    [Abstract] [Full Text] [Related]

  • 16. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S, Nunn C, Zupanc GK, Hoyer D.
    Auton Autacoid Pharmacol; 2005 Jan 15; 25(1):1-16. PubMed ID: 15659149
    [Abstract] [Full Text] [Related]

  • 17. Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay.
    Odagaki Y, Kinoshita M, Toyoshima R.
    Basic Clin Pharmacol Toxicol; 2011 Sep 15; 109(3):175-85. PubMed ID: 21443596
    [Abstract] [Full Text] [Related]

  • 18. Dopamine D1 receptor coupling to Gs/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)/antibody-capture characterization of benzazepine agonists.
    Mannoury la Cour C, Vidal S, Pasteau V, Cussac D, Millan MJ.
    Neuropharmacology; 2007 Mar 15; 52(3):1003-14. PubMed ID: 17178132
    [Abstract] [Full Text] [Related]

  • 19. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole.
    Millan MJ, Cussac D, Gobert A, Lejeune F, Rivet JM, Mannoury La Cour C, Newman-Tancredi A, Peglion JL.
    J Pharmacol Exp Ther; 2004 Jun 15; 309(3):903-20. PubMed ID: 14978194
    [Abstract] [Full Text] [Related]

  • 20. NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D(2) and serotonin 5-HT(2)receptors-implications for models of schizophrenia.
    Kapur S, Seeman P.
    Mol Psychiatry; 2002 Jun 15; 7(8):837-44. PubMed ID: 12232776
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.